Table 5 Comparison of clinical data for patients with and without statin therapy for Carotid
From: Variations in atherosclerosis and remodeling patterns in aorta and carotids
Demographics and risk factors | Mean ± S.D or % Statin(-) | (Range or dosage) Statin(+) | p |
|---|---|---|---|
Age (years) | 57.0 ± 12.5 (64-27) | 62.7 ± 4.9 (72-57) | ns |
Male sex (%) | 64.3 | 70.0 | ns |
Height (m) | 1.71 ± 0.09 (1.83-1.55) | 1.74 ± 0.05 (1.83-1.68) | ns |
Weight (kg) | 72.2 ± 14.6 (90-52) | 84.7 ± 17.7 (114-62) | ns |
Body Mass Index (kg/m2) | 24.6 ± 3.6 (28.8-18.9) | 28.0 ± 6.0 (39.2-23.4) | ns |
Hypertension (%) | 23.1 | 60.0 | ns |
Diabetes (%) | 18.2 | 40.0 | ns |
Smoking status (%) | Â | Â | Â |
   Active | 7.7 | 0.0 | ns |
   Quit | 38.5 | 60.0 | ns |
   Never | 53.8 | 40.0 | ns |
History of CAD (%) | 30.8 | 20.0 | ns |
Hypercholesterolemia (%) | 44.4 | 25.0 | ns |
Total cholesterol (mg/dl) | 200.4 ± 62.5 (130-287) | 176.1 ± 37.6 (128-244) | ns |
LDL cholesterol (mg/dl) | 127.1 ± 49.7 (65-202) | 102.6 ± 29.8 (62-147) | ns |
HDL cholesterol (mg/dl) | 54.8 ± 16.4 (33-86) | 48.0 ± 15.5 (30-77) | ns |
Triglycerides (mg/dl) | 106.0 ± 60.3 (46-234) | 116.4 ± 63.1 (48-233) | ns |